Marine chitosan-silver nano-particles as antibiotic synergizers against diabetic foot bacteria

Archives of Clinical Microbiology

Volumn 4, Issue 2, 2013, Pages

  Gohar, Yousry M ^a   Barakat, Khouloud M ^b   Abu Yousef, Morsy A ^a   Ghonam, Hasnaa B ^a  

^a Alexandria University Faculty Of Science   (Egypt)

^b NATIONAL INSTITUTE OF OCEANOGRAPHY AND FISHERIES   (Egypt)

Author keywords

Combination therapy; Drug resistance; Squilla chitosan siver nanoparticles; Synergy

Indexed keywords

EID: 84887385088     PISSN: None     EISSN: 19898436     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lipsky, BA., Giordano, P., Choudhri, S., Song, J. Treating diabetic foot infections with sequential intravenous to oral moxifloxacin compared with piperacillin-tazobactam/amoxicillin-clavulanate. J Antimicrob Chemother 2007; 60 (2): 370-376.
2. Stein GE, Schooley S, Peloquin CA, Missavage A, Havlichek DH. Linezolid tissue penetration and serum activity against strains of methicillin-resistant Staphylococcus aureus with reduced vancomycin susceptibility in diabetic patients with foot infections. J Antimicrob Chemother 2007; 60 (4): 819-823.
3. Falagas, ME., Bliziotis, IA., Kasiakou, SK. et al. Outcome of infections due to pandrug-resistant (PDR) Gram-negative bacteria. BMC Infec Dis. 2005; 5: 24-30.
4. Ling, TKW., Xiong, J., Yu, Y. et al. Multicenter antimicrobial susceptibility survey of Gram-negative bacteria isolated from patients with community-acquired infections in the People's Republic of China. Antimicrob Agents Chemother 2006; 50: 374-378.
5. Dawis, MA., Isenberg, HD., France, KA. et al. In vitro activity of gatifloxacin alone and in combination with cefepim, meropenem, piperacillin and gentamicin against multidrug-resistant organisms. J Antimicrob Chemother 2003; 51: 1203-1211.
6. Monden, K., Ando, E., Iida, M. et al. Role of fosfomycin in synergistic combination with ofloxacin against Pseudomonas aeruginosa growing in a biofilm. J Infect Chemother 2002; 8: 218-226.
7. Cernohorska, L., Votava, M. Antibiotic Synergy against Biofilm- Forming Pseudomonas aeruginosa. Folia Microbiol. 2008; 53: 57-60.
8. Neu, HC. Synergy and antagonism of combinations of quinolones. European J Clinic Microbiol Infec Dis. 1991; 10: 255-261.
9. onabedian H, Andriole VT (1977) Synergy of vancomycin with penicillins and cephalosporins against Pseudomonas, Klebsiella and Serratia. Yale J Biolo Med. 50:165-176.
10. Wise, R. Antimicrobial resistance: Paradox, actions and economics. J Antimicrob Chemother 2006; 57: 1024-1025.
11. Eweis, M., Elkholy, SS., Elsabee, MZ. Antifungal efficacy of chitosan and its thiourea derivatives upon the growth of some sugarbeet pathogens. Int J Biol Macromol. 2006; 1: 1-5.
12. Franklin, TJ., Snow, GA. Biochemistry of antimicrobial action, 3rd edn. Chapman and Hall, London, p 175. 1981.
13. Takemono, K., Sunamoto, J., Askasi, M. Polymers and medical care. Mita, Tokyo; chapter IV. 1989.
14. Decker, E-M., von Ohle, C., Weiger, R., Wiech, I., Brecx, MA. Synergistic chlorhexidine/chitosan combination for improved antiplaque strategies. J Period Res. 2005; 40: 373-377.
15. Tré-Hardy, M., Vanderbist, F., Traore, H., Devleeschouwer, MJ. In vitro activity of antibiotic combinations against Pseudomonas aeruginosa biofilm and planktonic cultures. Internat J Antimicrob Agents 2008; 35: 329-336.
16. Anil, KA., Stevens, WF. Chitosan-alginate multilayer beads for controlled release of ampicillin. Inter J Pharma. 2005; 290: 45-54.
17. Motwani, SK., Chopra, S., Talegaonkar, S., Kohli, K., Ahmad, FJ., Khar, RK. Chitosan-sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: Formulation, optimisation and in vitro characterization. European J Pharma Biopharma 2008; 68: 513-525.
18. Stee, C. Manual for identification of medical bacteria, 3rd edition. Barrow, G.I. and Felthan, R.K.A. Cambridge University Press, U.S.A. 1993.
19. Richard, S., Lynn, S-M., Avery, CG. Antimicrobial susceptibility testing protocols. New York: CRC Press. 2007.
20. Ding, CM., Yin, PC., Song, QP., Li, N., Qiao, YB. Preparation and characterization of complete deacetylized chitosan. J East China Univ Sci Technol. (Nat Sci Ed) 2005; 31(3): 296-299.
21. Bhavna, SV., Ali, M., Baboota, S., Ali, J. Preparation and characterization of chitosan nanoparticles for nose to brain delivery of a cholinesterase inhibitor. Ind J Pharm Sci. 2007; 69 (5): 712-723.
22. Andrews, JM. BSAC standardized disc susceptibility testing method. J Antimicrob Chemother 2001; 48 (1): 43-57.
23. Adewusi, OA., Oyedemi, S., Akinpelu, D., Okoh, A. Interactions of antibiotics and methanolic crude extracts of Afzelia Africana (Smith.) against drug resistance bacterial isolates. Intern J Molecul Sciences 2011; 12 (7): 4477-4487.
24. Oh, WS., Ko, KS., et al. Synergy of arbekacin-based combinations against vancomycin hetero-intermediate Staphylococcus aureus. J Korean Medic Science 2006; 21 (2): 188-192.
25. Mayer, BN., Ferrigni, NR., Putnam, JE., Jacobsen, LB., Nichols, DE. and Melaughhlin, JL. Brine Shrimp: Aconvenient General Bioassay for Active plant constituents. J Planta Medical 1982; 45: 31-34.
26. Motta, RN., Oliveira, MM., Magalhães, PSF., Dias, AM., Aragão, LP., Forti, AC., Carvalho, CBM. Plasmid mediated extended spectrum beta-lactamase producing strains of Enterobacteriacea isolated from diabetic foot infections in Brazilian diabetic centre. Braz J Infect Dis. 2003; 7: 129-134.
27. Ravisekhar, G., Bernu, D., Vishnub hartla, S., Arti, K., Ammini, AC., Rama, C. Clinical microbiological study of diabetic foot ulcers in an Indian tertiary-care hospital. Diabetic Care 2006; 29: 1727-1732.
28. Alavi, SM., Khosravi, AD., Sarami, A., Dashtebozorg, A., Abasi, E. Bacteriologic study of diabetic foot ulcer. Pak J Med Sci. 2007; 23 (5): 681-684.
29. Hayat, AS., Khan, AH., Masood, N., Shaikh, N. Study for microbiological pattern and in vitro antibiotic susceptibility in patients having diabetic infections at tertiary care hospital in Abbottabad. World App Sci J 2011; 12 (2): 123-131.
30. Pramodhini, S., Niveditha, S., Umadevi, S., Kumar, S., Stephen, S. Antiobiotic resistance pattern of biofilm{replacement character}forming uropathogens isolated from catheterized patients in Pondicherry. India Austr Medic J [AMJ] 2012; 5 (7): 344-348.
31. Tin, S., Sakharkar, KR., Lim, CS., Sakharkar, MK. Activity of Chitosans in combination with antibiotics in Pseudomonas aeruginosa. Int J Biol Sci. 2009; 5 (2): 153-160.
32. Yin, X., Chen, J., Yuan, W., Lin, Q., Ji, L., Liu, F. Preparation and antibacterial activity of Schiff bases from O-carboxymethyl chitosan and para-substituted Benzaldehydes. Polym Bull 2012; 68: 1215-1226.
33. Balogh, L., Swanson, DR., Tomalia, DA., Hagnauer, GL., McManus, AT. Silver Complexes and Nanocomposites as Antimicrobial Agents. Nano Letters 2001; 1 (1): 18-21.
34. Raafat, D., von Bargen, K., Haas, A., Sahl, H. Insight into the mode of action of Chitosan as an Antibacterial Compound. Appl Environ Microbiol. 2008; 74: 3764-3773.
35. Huang, L., Dai, T., Xuan, Y., Tegos, GP., Hamblin, MR. Synergistic combination of chitosan acetate with nanoparticle silver as a topical antimicrobial: Efficacy against bacterial burn infections. Antimicrob Agents Chemother 2011; 55 (7): 3432-3438.